The aesthetics market is once again in the spotlight for the wrong reasons following reports that UK health watchdog NICE (The National Institute for Health and Care Excellence) has issued concerns that consumers of invasive treatments such as Botox and dermal fillers could be at risk of infection from dirty needles.
According to NICE, it has seen a rise in the number of drugs used for vanity and image-enhancing purposes, and of more concern, anecdotal evidence that teens are administering these substances themselves with no proper training or qualification. It fears this could lead to an increased risk of the spread of blood-borne diseases such as hepatitis C and HIV due to poor hygiene practices.
As a result, NICE is to update its advice, with the aim of raising awareness of the dangers of needle sharing and encouraging consumers to use sterile needles and syringes.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.